Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:483748.
doi: 10.1155/2012/483748. Epub 2012 Dec 26.

The risk of acute kidney injury and its impact on 30-day and long-term mortality after transcatheter aortic valve implantation

Affiliations

The risk of acute kidney injury and its impact on 30-day and long-term mortality after transcatheter aortic valve implantation

Katrin Gebauer et al. Int J Nephrol. 2012.

Abstract

Background. Transcatheter aortic valve implantation (TAVI) is widely used in high risk patients (pts) with aortic stenosis. Underlying chronic kidney disease implicates a high risk of postprocedural acute kidney injury (AKI). We analyzed its occurrence, impact on hospital stay, and mortality. Methods. 150 consecutive pts underwent TAVI in our institution (mean age 81 ± 7 years; logistic EuroSCORE 24 ± 15%). AKI definition was a creatinine rise of 26.5 μmol/L or more within 48 hours postprocedural. Ten patients on chronic hemodialysis were excluded. Results. AKI occurred in 28 pts (20%). Baseline creatinine was higher in AKI pts (126.4 ± 59.2 μmol/L versus 108.7 ± 45.1 μmol/L, P = 0.09). Contrast media use was distributed evenly. Both, 30-day mortality (29% versus 7%, P < 0.0001) and long-term mortality (43% versus 18%, P < 0.0001) were higher; hospital stay was longer in AKI pts (20 ± 12 versus 15 ± 10 days, P = 0.03). Predicted renal failure calculated STS Score was similar (8.0 ± 5.0% [AKI] versus 7.1 ± 4.0% [non-AKI], P = 0.32) and estimated lower renal failure rates than observed. Conclusion. AKI remains a frequent complication with increased mortality in TAVI pts. Careful identification of risk factors and development of more suitable risk scores are essential.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cumulative survival in pts. with (dotted lines) and without AKI (solid lines). (a) Crude cumulative survival (days) (HRR 2.7, CI 1.34–5.41, P < 0.01). (b) Adjusted cumulative survival (days) (HRR 3.8, CI 1.37–10.37, P = 0.01); adjusted for age, diabetes, PAD, hypertension, previous myocardial infarction and CABG, left ventricular function, amount of contrast dye, baseline creatinine, and hemoglobin.
Figure 2
Figure 2
Morbidity and mortality with respect to access site and development of acute kidney injury (AKI): observed 30-day mortality and predicted renal failure and mortality by STS Score for pts. with and without AKI; AKI = acute kidney injury.

References

    1. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. European Heart Journal . 2003;24(13):1231–1243. - PubMed
    1. Sack S, Schofer J. Transcatheter-based aortic valve implantation. Present and future technologies. Herz . 2009;34(5):357–366. - PubMed
    1. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation . 2002;106(24):3006–3008. - PubMed
    1. McCullough PA. Contrast-Induced Acute Kidney Injury. Journal of the American College of Cardiology . 2008;51(15):1419–1428. - PubMed
    1. Lindsay J, Apple S, Pinnow EE, et al. Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine. Catheterization and Cardiovascular Interventions . 2003;59(3):338–343. - PubMed

LinkOut - more resources